About this trial
This study involves collecting paired tumor samples from intrasellar and cavernous sinus regions of 20 invasive pituitary tumor patients, preserving them at -80°C for quality multi-omics analysis. Proteomics and transcriptomics are employed to identify molecular differences, while imaging data (MRI/CT) assesses tumor morphology and invasion. In vitro experiments and mechanistic studies validate key findings, exploring how regional molecular differences affect tumor behavior. Data integration combines multi-omics and imaging features to uncover biomarkers and pathways associated with invasiveness and regional specificity, with statistical analysis ensuring significance and reliability.
Eligibility criteria
Qualifiers
Invasive pituitary tumors involving the cavernous sinus
Retrospective inclusion of patients who have signed informed consent forms for the donation of biological samples and health-related information
Age range: 18-80 years
Subjects are willing to participate in this study
Disqualifiers
Non-invasive pituitary tumors
Pregnant or breastfeeding
Other conditions deemed unsuitable for participation in this clinical trial as assessed by the physician
Trial design
Treatments tested in this trial
- surgery